Equifax (NYSE:EFX – Get Free Report) had its price objective lowered by investment analysts at Oppenheimer from $286.00 to $279.00 in a note issued to investors on Friday,Benzinga reports. The firm presently has an “outperform” rating on the credit services provider’s stock. Oppenheimer’s price target suggests a potential upside of 13.32% from the company’s previous close.
A number of other research firms have also recently commented on EFX. Needham & Company LLC cut their target price on Equifax from $325.00 to $300.00 and set a “buy” rating on the stock in a research note on Friday. UBS Group cut their target price on Equifax from $335.00 to $310.00 and set a “buy” rating on the stock in a research note on Friday. Robert W. Baird increased their target price on Equifax from $290.00 to $333.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Stifel Nicolaus cut their target price on Equifax from $284.00 to $281.00 and set a “buy” rating on the stock in a research note on Friday. Finally, William Blair reissued an “outperform” rating on shares of Equifax in a research note on Friday. Two investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $303.94.
Get Our Latest Stock Report on Equifax
Equifax Trading Down 0.5 %
Equifax (NYSE:EFX – Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The credit services provider reported $2.12 earnings per share for the quarter, meeting the consensus estimate of $2.12. Equifax had a return on equity of 18.56% and a net margin of 10.07%. As a group, equities research analysts expect that Equifax will post 7.27 earnings per share for the current fiscal year.
Insider Buying and Selling at Equifax
In other news, EVP Lisa M. Nelson sold 551 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $260.39, for a total value of $143,474.89. Following the transaction, the executive vice president now owns 11,697 shares of the company’s stock, valued at $3,045,781.83. This trade represents a 4.50 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.66% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the stock. Czech National Bank grew its position in shares of Equifax by 7.0% during the third quarter. Czech National Bank now owns 25,206 shares of the credit services provider’s stock worth $7,407,000 after purchasing an additional 1,651 shares in the last quarter. Diversified Trust Co purchased a new stake in shares of Equifax during the third quarter worth about $231,000. CWM LLC grew its position in shares of Equifax by 6.5% during the third quarter. CWM LLC now owns 1,520 shares of the credit services provider’s stock worth $447,000 after purchasing an additional 93 shares in the last quarter. Wedmont Private Capital grew its position in shares of Equifax by 6.9% during the third quarter. Wedmont Private Capital now owns 2,578 shares of the credit services provider’s stock worth $727,000 after purchasing an additional 167 shares in the last quarter. Finally, LVW Advisors LLC grew its position in shares of Equifax by 10.2% during the third quarter. LVW Advisors LLC now owns 3,644 shares of the credit services provider’s stock worth $1,071,000 after purchasing an additional 337 shares in the last quarter. Institutional investors own 96.20% of the company’s stock.
About Equifax
Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.
Featured Stories
- Five stocks we like better than Equifax
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Energy and Oil Stocks Explained
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
- How to Most Effectively Use the MarketBeat Earnings Screener
- High-Momentum ETFs Leading the Market This Year
Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.